Biofrontera Inc公布积极二期B阶段结果 支持Ameluz®光动力疗法针对中重度痤疮的进一步开发

美股速递
Mar 09

Biofrontera Inc宣布其Ameluz®光动力疗法在治疗中重度寻常型痤疮的二期B阶段临床试验中取得积极结果。该结果有力支持该疗法的后续研发推进。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10